Search Result "IL13-PE38"
Clinical Studies with Targeted Toxins in Malignant Glioma
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 2 Year: 2006 Page: 119-131
Author(s): Nikolai G. Rainov, Ariane Soling
Convection Enhanced Drug Delivery of Novel Therapeutic Agents to Malignant Brain Tumors
Journal: Current Drug Delivery
Volume: 4 Issue: 2 Year: 2007 Page: 169-180
Author(s): Sherise Ferguson, Maciej S. Lesniak
Clinical Trials with Intracerebral Convection-Enhanced Delivery of Targeted Toxins in Malignant Glioma
Journal: Reviews on Recent Clinical Trials
Volume: 3 Issue: 1 Year: 2008 Page: 2-9
Author(s): N. G. Rainov, K. Gorbatyuk, V. Heidecke
Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment
Journal: Current Neuropharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 116-128
Author(s): Zhiping Zhou, Ranjodh Singh, Mark M. Souweidane
Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11 Issue: 8 Year: 2011 Page: 729-738
Author(s): Marianela Candolfi, Kurt M. Kroeger, Weidong Xiong, Chunyan Liu, Mariana Puntel, Kader Yagiz, AKM Ghulam Muhammad, Yohei Mineharu, David Foulad, Mia Wibowo, Hikmat Assi, Gregory J. Baker, Pedro R. Lowenstein, Maria G. Castro
Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1979-1983
Author(s): Maddalena de Virgilio, Franco Silvestris
Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Journal: Current Cancer Drug Targets
Volume: 4 Issue: 8 Year: 2004 Page: 689-702
Author(s): P. Michl, T. M. Gress
Cancer Gene Therapy Utilizing Interleukin-13 Receptor α2 Chain
Journal: Current Gene Therapy
Volume: 5 Issue: 2 Year: 2005 Page: 213-223
Author(s): Koji Kawakami
Targeted Tumor Therapies at a Glance
Journal: Current Drug Targets
Volume: 10 Issue: 2 Year: 2009 Page: 89-93
Author(s): H. Fuchs, C. Bachran
Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 2652-2664
Author(s): Robert J. Kreitman